TSC22D3 as an Immune-Related Prognostic Biomarker for Acute Myeloid Leukemia
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Original data, statistical description and data analysis
应用场景：
创建时间：
2023-07-11
相关数据集
DataSheet_1_Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients.docx
BackgroundBiomarkers predicting treatment response may be used to stratify patients with pancreatic ductal adenocarcinoma (PDAC) for available therapies. The aim of this study was to evaluate the asso
NIAID Data Ecosystem50
Additional file 4 of LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia
Additional file 4: Table S4. the identified lncRNA, miRNA and mRNA in the ceRNA network.
Figshare2020-09-04 更新20
Data Sheet 1_Soluble HLA-G is related to malignant melanocytic lesions and previous oncological disease may increase circulating HLA-G bearing large extracellular vesicles.pdf
IntroductionHuman leukocyte antigen G (HLA-G) can induce tumor immune escape, facilitating tumor progression. Extracellular vesicles (EVs) are also involved in tumor progression, due to its activity o
NIAID Data Ecosystem10
Table1_Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer.DOCX
Lymphocyte antigen 96 (LY96) is implicated in tumorigenesis by modulating host immunity. However, an integrated pan-cancer analysis of LY96 in prognosis and immunotherapy across human cancers is still
NIAID Data Ecosystem30
DataSheet_2_High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia.zip
Acute myelogenous leukemia (AML) is a disease that severely affects the physical health of children. Thus, we aimed to identify biomarkers associated with AML prognosis in children. Using transcriptom
NIAID Data Ecosystem20
